)
Catalyst Pharmaceuticals (CPRX) investor relations material
Catalyst Pharmaceuticals 44th Annual J.P. Morgan Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Company overview and strategy
Focuses on rare diseases with a commercial-stage model, leveraging in-licensing, acquisition, and development of therapies for underserved conditions.
Operates a patient-first approach with bespoke support programs, high compliance rates, and a specialized pharmacy hub.
Maintains profitability, over $700 million in cash, no funded debt, and capacity for $1 billion in acquisitions.
Pursues both organic and inorganic growth, seeking immediately or nearly immediately accretive opportunities.
Expanding mandate to include products in development, targeting peak sales up to $500 million and global rights.
Product portfolio and market performance
FIRDAPSE is the only evidence-based treatment for Lambert-Eaton myasthenic syndrome (LEMS), with a $1 billion addressable market and 15%-20% quarterly growth.
AGAMREE, a differentiated steroid for Duchenne muscular dystrophy (DMD), launched in March 2024, showing 224% growth through September 2025.
FYCOMPA, for epilepsy, continues to outperform competitors despite generic entry, supporting cash flow.
FIRDAPSE market split is nearly 50/50 between cancer-associated and idiopathic LEMS, with the former slightly larger.
AGAMREE is gaining rapid adoption, with 90% of top centers using it and high conversion from existing steroids.
Patient support and access initiatives
Offers free bridge medication, insurance navigation, and broad co-pay programs to ensure therapy access.
Patient advocacy liaisons and ambassador programs support education and peer engagement.
High-touch specialty pharmacy and direct-to-patient outreach drive 90% retention and compliance.
Focused on reducing diagnostic delays, especially for LEMS, and leveraging machine learning for patient identification.
Collaborates with independent advocacy groups to expand patient support.
Next Catalyst Pharmaceuticals earnings date
Next Catalyst Pharmaceuticals earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)